Effects of Systane® Balance on noninvasive tear film break-up time in patients with lipid-deficient dry eye

Código QR

Effects of Systane® Balance on noninvasive tear film break-up time in patients with lipid-deficient dry eye

Alejandro J Aguilar, Maria I Marquez, Paula A Albera, Jorge L Tredicce, Alejandro Berra Universidad de Buenos Aires, Buenos Aires, Argentina Purpose: To evaluate the ability of Systane® Balance (SYSB) administered four times per day for 4 weeks to increase noninvasive tear film break-up t...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Aguilar AJ, Marquez MI, Albera P, Tredicce JL, Berra A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/02f0c0bccbba429f804b73cc59a6cd6c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Systane&reg; lubricant eye drops in the management of ocular dryness
por: Benelli U
Publicado: (2011)

A randomized clinical evaluation of the safety of Systane&reg; Lubricant Eye Drops for the relief of dry eye symptoms following LASIK refractive surgery
por: Daniel Durrie, et al.
Publicado: (2008)

Efficacy of polyethylene glycol–propylene glycol-based lubricant eye drops in reducing squamous metaplasia in patients with dry eye disease
por: Aguilar A, et al.
Publicado: (2018)

A novel system, TearCare®, for the treatment of the signs and symptoms of dry eye disease
por: Badawi D
Publicado: (2018)

Severe symptoms of short tear break-up time dry eye are associated with accommodative microfluctuations
por: Kaido M, et al.
Publicado: (2017)

Reliability and efficacy of maximum fluorescein tear break-up time in diagnosing dry eye disease
por: Yujie Mou, et al.
Publicado: (2021)

Effect of Refresh Plus® preservative-free lubricant eyedrops on tear ferning patterns in dry eye and normal eye subjects
por: Alanazi SA, et al.
Publicado: (2019)

TearCare® system extension study: evaluation of the safety, effectiveness, and durability through 12 months of a second TearCare® treatment on subjects with dry eye disease
por: Badawi D
Publicado: (2019)

Assessment of dry eye signs and symptoms and ocular tolerance of a preservative-free lacrimal substitute (Hylabak®) versus a preserved lacrimal substitute (Systane®) used for 3 months in patients after LASIK
por: Astakhov YS, et al.
Publicado: (2013)

Advances in the Noninvasive Diagnosis of Dry Eye Disease
por: Luca Di Cello, et al.
Publicado: (2021)

Tear osmolarity and dry eye symptoms in diabetics
por: Fuerst N, et al.
Publicado: (2014)

Tear film break-up patterns in thyroid eye disease
por: Yasuhiro Takahashi, et al.
Publicado: (2021)

A Decade of Effective Dry Eye Disease Management with Systane Ultra (Polyethylene Glycol/Propylene Glycol with Hydroxypropyl Guar) Lubricant Eye Drops
por: Srinivasan S, et al.
Publicado: (2021)

PACAP suppresses dry eye signs by stimulating tear secretion
por: Tomoya Nakamachi, et al.
Publicado: (2016)

Changes in Tear Proteome After Acupuncture Treatment in Dry Eye
por: Tong L, et al.
Publicado: (2021)

A two-week clinical evaluation of the safety of Systane&reg; Ultra in contact lens-wearing patients
por: David Kading
Publicado: (2010)

Tear film osmolarity and dry eye disease: a review of the literature
por: Potvin R, et al.
Publicado: (2015)

One month use of Systane&reg; improves ocular surface parameters in subjects with moderate symptoms of ocular dryness
por: Piera Versura, et al.
Publicado: (2008)

Evaluation of a new artificial tear formulation for the management of tear film stability and visual function in patients with dry eye
por: Torkildsen G, et al.
Publicado: (2017)

Effects of short-term oral vitamin A supplementation on the ocular tear film in patients with dry eye
por: Alanazi SA, et al.
Publicado: (2019)

Efficacy of an artificial tear emulsion in patients with dry eye associated with meibomian gland dysfunction
por: Sindt CW, et al.
Publicado: (2013)

Effect of thermal pulsation treatment on tear film parameters in dry eye disease patients
por: Kim MJ, et al.
Publicado: (2017)

Evaluation of tear osmolarity measured by I-Pen osmolarity system in patients with dry eye
por: Jongyeop Park, et al.
Publicado: (2021)

A Prospective, Post-Market, Multicenter Trial (CHEETAH) Suggested TearCare® System as a Safe and Effective Blink-Assisted Eyelid Device for the Treatment of Dry Eye Disease
por: Karpecki P, et al.
Publicado: (2020)

Longitudinal changes in dry eye symptoms and signs following lifitegrast therapy and relationship to tear osmolarity
por: Pepose JS, et al.
Publicado: (2019)

Improved Tear Film Stability in Patients with Dry Eye After Hyaluronic Acid and Galactoxyloglucan Use
por: Molina-Solana P, et al.
Publicado: (2020)

Comparison and Evaluation of Prelens Tear Film Stability by Different Noninvasive in vivo Methods
por: Itokawa T, et al.
Publicado: (2020)

Optical Quality and Tear Film Analysis Before and After Intranasal Stimulation in Patients with Dry Eye Syndrome
por: Passi SF, et al.
Publicado: (2020)

Effects of Intense Pulsed Light on Tear Film TGF-β and Microbiome in Ocular Rosacea with Dry Eye
por: Sagaser S, et al.
Publicado: (2021)

Evaluation of Tear Film Urea Level as a Diagnostic Marker of Dry Eye Disease: A Pilot Study
por: Gurunadh Satyanarayana Velamakanni, et al.
Publicado: (2021)

Impression cytology implicates cell autophagy in aqueous deficiency dry eye
por: Lin T, et al.
Publicado: (2017)

Tear lipid layer thickness with eye drops in meibomian gland dysfunction
por: Fogt JS, et al.
Publicado: (2016)

The clinical utility of FibroScan® as a noninvasive diagnostic test for liver disease
por: Wilder J, et al.
Publicado: (2014)

A prospective, multicenter, noninterventional study of Optive Plus® in the treatment of patients with dry eye: the prolipid study
por: Kaercher T, et al.
Publicado: (2014)

A randomized multicenter study comparing seawater washes and carmellose artificial tears eyedrops in the treatment of dry eye syndrome
por: Diaz-Llopis M, et al.
Publicado: (2019)

Lacrimal proline rich 4 (LPRR4) protein in the tear fluid is a potential biomarker of dry eye syndrome.
por: Saijyothi Venkata Aluru, et al.
Publicado: (2012)

A nonrandomized, open-label study to evaluate the effect of nasal stimulation on tear production in subjects with dry eye disease
por: Friedman NJ, et al.
Publicado: (2016)

Use of preservative-free hyaluronic acid (Hylabak®) for a range of patients with dry eye syndrome: experience in Russia
por: Brzhesky VV, et al.
Publicado: (2014)

Efficacy of Artificial Tears Based on an Extract of <i>Artemia salina</i> Containing Dinucleotides in a Rabbit Dry Eye Model
por: Carlos Carpena-Torres, et al.
Publicado: (2021)

Real-life results of switching from preserved to preservative-free artificial tears containing hyaluronate in patients with dry eye disease
por: Nasser L, et al.
Publicado: (2018)